Church of PeptidesSearch
Portrait of NAD+
The Narthex · Non-peptide visitor

NAD+

The Ancient Battery

Global cellular biology

NAD+ is a coenzyme used in cellular energy transfer and other biochemical reactions. It is not a peptide. Its essential role inside cells is distinct from the evidence for administering it as a wellness intervention.

Evidence ladder: Claim-specific reviewEstablished biology; intervention-specific evidence variesEducational record
ClassificationThe Narthex
Evidence summaryEstablished biology; intervention-specific evidence varies
OriginGlobal cellular biology
A visitor’s account · comic scripture

The laboratory legend

NAD+ reached the church doors carrying energy for nearly every cell. The clergy examined its papers and declared, “Important, ancient and welcome—but no peptide bonds.” A place was prepared in the Narthex.

This bold passage is invented comedy, not scientific or historical fact.
Documented history

From cellular biology to infusion research

A 2019 human pilot followed NAD+ and related metabolites during and after an intravenous infusion. It included eight treated men and three controls. This was a study of metabolic handling, not a demonstration of longer life or broad wellness improvement. Read the original pilot.

Global cellular biology · Not a peptide
Scientific record

What the evidence says

Established biology or proposed benefit

  • Essential coenzyme in cellular redox and energy metabolism.
  • Its biological role across tissues is well established.

Risks, claims, and limits

  • NAD+ is not a peptide.
  • Biological importance does not prove broad benefits from every injection, infusion, supplement, or wellness claim.
Doctide’s verdict

The Ancient Battery belongs in the Narthex for its biology. Recharging the metaphor is easy; demonstrating better health from a particular intervention requires measured clinical outcomes.

Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 20, 2026
Evidence ledger

Sources

Source links checked: October 4, 2026. This small human pilot examined metabolism during an infusion; it did not establish longevity or wellness benefits.

  1. 2019 pilot study: metabolism during intravenous NAD+
  2. FDA Drugs@FDA database
  3. Grant et al., 2019: original intravenous NAD+ pilot

Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.